When Antidepressants Haven't Worked: Treatment-Resistant Depression
You are not out of options. Allen Psychiatry offers the full range of next-step treatments — medication re-evaluation, TMS, Spravato®, and intensive programs — on one campus in Allen, TX.
What Is Treatment-Resistant Depression?
Treatment-resistant depression (TRD) generally describes major depressive disorder that has not improved adequately after trying two or more antidepressant medications at an appropriate dose and for an appropriate length of time. It does not mean depression that cannot be treated — it means the first treatments tried were not the right fit, and different, evidence-based options should be considered.
Common experiences when depression hasn't responded to medication
Persistent low mood despite taking antidepressants as prescribed
Loss of interest or pleasure in activities
Fatigue and low energy
Changes in sleep or appetite
Difficulty concentrating
Feelings of hopelessness or worthlessness
Thoughts of self-harm or suicide
If any of these describe you despite trying antidepressants, a re-evaluation with a psychiatric provider is the right next step — not giving up on treatment.
How We Treat Treatment-Resistant Depression, All in One Place
Allen Psychiatry provides every level of care on one campus, so your treatment plan can adapt — up or down — without changing practices.
Step 1: A fresh look at your medications
The first step is often a careful re-evaluation rather than a new prescription. Our psychiatric providers review what you have tried, at what doses, and for how long — and whether the diagnosis itself needs a second look. Sometimes an adjusted dose, a switch, or an augmentation strategy makes a meaningful difference before more intensive options are needed.
Learn more about Medication ManagementTMS: medication-free brain stimulation
Transcranial magnetic stimulation (TMS) is an FDA-cleared, non-invasive option for adults whose depression has not responded adequately to antidepressant medication. Treatment is delivered in brief daily sessions over several weeks using our NeuroStar system, with no anesthesia and no systemic medication side effects. You can drive yourself to and from sessions and continue normal daily activities.
Learn more about TMS TherapySpravato: FDA-approved specifically for TRD
Spravato (esketamine) nasal spray is FDA-approved for treatment-resistant depression and is taken together with an oral antidepressant. Each dose is administered in our REMS-certified center with post-dose monitoring by our clinical team. Spravato works through a different mechanism than standard antidepressants, which is why it can help when other medications have not.
Learn more about Spravato® (esketamine)When you need more structure: PHP & IOP
If depression is significantly disrupting daily life, our partial hospitalization (PHP) and intensive outpatient (IOP) programs provide structured, multi-day-per-week treatment — group therapy, individual support, and close psychiatric oversight — without an inpatient stay. Many patients use these programs as a bridge: stabilizing first, then stepping down to routine outpatient care with the same practice.
Learn more about PHP & IOP ProgramsRelated reading: Depression
This page is for general education from a patient's perspective — it is not medical advice, a diagnosis, or a substitute for an evaluation with a qualified provider. Which treatment fits you is a decision made together with your psychiatric provider.
Treatment-Resistant Depression FAQs
Straight answers to the questions patients actually ask
Still have questions? We're here to help.
If You Are in Immediate Danger
If you or someone you know is in immediate danger of self-harm or suicide:
Depression That Hasn't Responded Still Has Options
Start with a psychiatric evaluation. We'll review what you've tried, verify your insurance benefits, and map the next step together.
Individual results may vary. Treatment is not suitable for everyone and requires a comprehensive evaluation by a qualified provider to determine appropriateness.
